ArticleNPJ precision oncology2026

Validation of QuANTUM-derived tumor cell fraction for molecular testing in high-grade serous tubo-ovarian carcinoma.

Antonio Maria Alviano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.